cilostazol has been researched along with 8-bromo cyclic adenosine monophosphate in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoki, M; Hayashi, S; Higaki, J; Matsushita, H; Morishita, R; Nakagami, H; Nakamura, T; Ogihara, T; Taniyama, Y; Yamamoto, K | 1 |
| Aoki, M; Hayashi, S; Jo, N; Kaneda, Y; Matsumoto, K; Morishita, R; Nakamura, T; Ogihara, T | 1 |
| Chang, YC; Kim, CS; Kim, HS; Kim, MJ; Kim, SY; Lee, IK; Lee, KM; Lee, KU; Lee, SL; Park, JY; Park, KG | 1 |
| Adachi, S; Akamatsu, S; Doi, T; Enomoto, Y; Iwama, T; Kato, K; Kozawa, O; Matsushima-Nishiwaki, R; Natsume, H; Ogura, S; Otsuka, T; Tokuda, H; Yoshimura, S | 1 |
| Baek, AE; Kanthi, Y; Liao, H; Pinsky, DJ; Sutton, NR | 1 |
5 other study(ies) available for cilostazol and 8-bromo cyclic adenosine monophosphate
| Article | Year |
|---|---|
Cyclic AMP inhibited proliferation of human aortic vascular smooth muscle cells, accompanied by induction of p53 and p21.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Aorta; Apoptosis; Arteriosclerosis; Blotting, Western; Cell Division; Cells, Cultured; Cilostazol; Colforsin; Constriction, Pathologic; Cyclic AMP; DNA Fragmentation; Gene Expression Regulation; Humans; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Proto-Oncogene Proteins p21(ras); Recombinant Proteins; Tetrazoles; Tumor Suppressor Protein p53; Vasodilator Agents | 2000 |
Inhibition of neointimal formation after balloon injury by cilostazol, accompanied by improvement of endothelial dysfunction and induction of hepatocyte growth factor in rat diabetes model.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Acetylcholine; Animals; Aorta; Arteries; Carotid Arteries; Catheterization; Cell Death; Cell Hypoxia; Cells, Cultured; Cilostazol; Coculture Techniques; Colforsin; Cyclic AMP; Diabetes Mellitus, Experimental; Endothelium, Vascular; Hepatocyte Growth Factor; Humans; Kinetics; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Rats; Rats, Sprague-Dawley; Tetrazoles | 2001 |
Cilostazol inhibits vascular smooth muscle cell growth by downregulation of the transcription factor E2F.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Carotid Artery Injuries; Catheterization; Cell Cycle Proteins; Cell Division; Cells, Cultured; Cilostazol; Colforsin; Cyclic AMP; DNA; DNA-Binding Proteins; Down-Regulation; E2F Transcription Factors; E2F1 Transcription Factor; E2F2 Transcription Factor; Humans; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Proliferating Cell Nuclear Antigen; Promoter Regions, Genetic; Rats; Rats, Sprague-Dawley; Tetrazoles; Transcription Factors; Tunica Intima | 2005 |
cAMP regulates ADP-induced HSP27 phosphorylation in human platelets.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenosine Diphosphate; Blood Platelets; CD40 Ligand; Cilostazol; Cyclic AMP; HSP27 Heat-Shock Proteins; Humans; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Platelet Aggregation; Platelet-Derived Growth Factor; Tetrazoles | 2011 |
Regulation of ecto-apyrase CD39 (ENTPD1) expression by phosphodiesterase III (PDE3).
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenosine Triphosphatases; Antigens, CD; Apyrase; Cilostazol; Cyclic Nucleotide Phosphodiesterases, Type 3; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Human Umbilical Vein Endothelial Cells; Humans; Macrophages; Milrinone; Tetrazoles; Transcription, Genetic; Ubiquitination | 2013 |